Annual Operating Profit
-$26.35 M
+$10.34 M+28.17%
December 31, 2021
Summary
- As of February 10, 2025, IDRA annual operating income is -$26.35 million, with the most recent change of +$10.34 million (+28.17%) on December 31, 2021.
- During the last 3 years, IDRA annual operating profit has risen by +$30.25 million (+53.44%).
Performance
IDRA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Profit
-$3.69 M
+$1.68 M+31.24%
September 30, 2022
Summary
- As of February 10, 2025, IDRA quarterly operating income is -$3.69 million, with the most recent change of +$1.68 million (+31.24%) on September 30, 2022.
- Over the past year, IDRA quarterly operating profit has increased by +$2.15 million (+36.81%).
Performance
IDRA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Operating Profit
-$17.36 M
+$2.15 M+11.02%
September 30, 2022
Summary
- As of February 10, 2025, IDRA TTM operating income is -$17.36 million, with the most recent change of +$2.15 million (+11.02%) on September 30, 2022.
- Over the past year, IDRA TTM operating profit has increased by +$12.91 million (+42.66%).
Performance
IDRA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
IDRA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.2% | +36.8% | +42.7% |
| 3 y3 years | +53.4% | +67.6% | +62.2% |
| 5 y5 years | +59.7% | +74.8% | +62.2% |
IDRA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +45.4% | at high | +51.8% |
| 5 y | 5-year | at high | +74.1% | at high | +256.5% | at high | +175.4% |
| alltime | all time | -265.0% | +148.0% | -116.3% | +485.3% | -145.3% | +285.6% |
Idera Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$3.69 M(-31.2%) | -$17.36 M(-11.0%) |
| Jun 2022 | - | -$5.37 M(+28.3%) | -$19.51 M(-4.9%) |
| Mar 2022 | - | -$4.18 M(+1.5%) | -$20.51 M(-22.2%) |
| Dec 2021 | -$26.35 M(-28.2%) | -$4.12 M(-29.4%) | -$26.35 M(-12.9%) |
| Sep 2021 | - | -$5.84 M(-8.3%) | -$30.27 M(-5.2%) |
| Jun 2021 | - | -$6.37 M(-36.5%) | -$31.92 M(-4.9%) |
| Mar 2021 | - | -$10.03 M(+24.7%) | -$33.56 M(-8.5%) |
| Dec 2020 | -$36.69 M(-20.0%) | -$8.04 M(+7.4%) | -$36.69 M(-9.3%) |
| Sep 2020 | - | -$7.48 M(-6.6%) | -$40.44 M(-8.8%) |
| Jun 2020 | - | -$8.01 M(-39.1%) | -$44.33 M(-7.2%) |
| Mar 2020 | - | -$13.15 M(+11.6%) | -$47.79 M(+4.2%) |
| Dec 2019 | -$45.89 M(-18.9%) | -$11.79 M(+3.6%) | -$45.89 M(-1.3%) |
| Sep 2019 | - | -$11.38 M(-0.8%) | -$46.50 M(-2.8%) |
| Jun 2019 | - | -$11.47 M(+2.0%) | -$47.82 M(-6.4%) |
| Mar 2019 | - | -$11.24 M(-9.3%) | -$51.06 M(-9.8%) |
| Dec 2018 | -$56.60 M(-13.4%) | -$12.40 M(-2.3%) | -$56.60 M(-2.6%) |
| Sep 2018 | - | -$12.70 M(-13.7%) | -$58.09 M(-3.3%) |
| Jun 2018 | - | -$14.72 M(-12.3%) | -$60.06 M(-10.3%) |
| Mar 2018 | - | -$16.78 M(+20.8%) | -$66.93 M(+2.4%) |
| Dec 2017 | -$65.34 M(+68.6%) | -$13.89 M(-5.3%) | -$65.34 M(+28.9%) |
| Sep 2017 | - | -$14.67 M(-32.1%) | -$50.70 M(+3.4%) |
| Jun 2017 | - | -$21.59 M(+42.2%) | -$49.01 M(+19.5%) |
| Mar 2017 | - | -$15.19 M(-2144.1%) | -$41.03 M(+5.9%) |
| Dec 2016 | -$38.76 M(-20.7%) | $743.00 K(-105.7%) | -$38.76 M(-24.9%) |
| Sep 2016 | - | -$12.98 M(-4.6%) | -$51.58 M(+3.0%) |
| Jun 2016 | - | -$13.61 M(+5.3%) | -$50.07 M(+1.7%) |
| Mar 2016 | - | -$12.92 M(+6.9%) | -$49.24 M(+0.8%) |
| Dec 2015 | -$48.85 M(+26.0%) | -$12.08 M(+5.4%) | -$48.85 M(+0.3%) |
| Sep 2015 | - | -$11.46 M(-10.3%) | -$48.69 M(+4.2%) |
| Jun 2015 | - | -$12.78 M(+2.0%) | -$46.75 M(+10.5%) |
| Mar 2015 | - | -$12.52 M(+5.0%) | -$42.30 M(+9.2%) |
| Dec 2014 | -$38.75 M(+113.3%) | -$11.93 M(+25.3%) | -$38.75 M(+17.8%) |
| Sep 2014 | - | -$9.52 M(+14.3%) | -$32.90 M(+17.2%) |
| Jun 2014 | - | -$8.33 M(-7.2%) | -$28.06 M(+20.4%) |
| Mar 2014 | - | -$8.97 M(+47.8%) | -$23.29 M(+28.2%) |
| Dec 2013 | -$18.17 M(-8.7%) | -$6.07 M(+29.7%) | -$18.17 M(+10.6%) |
| Sep 2013 | - | -$4.68 M(+31.3%) | -$16.43 M(-0.4%) |
| Jun 2013 | - | -$3.57 M(-7.3%) | -$16.50 M(-9.6%) |
| Mar 2013 | - | -$3.85 M(-11.2%) | -$18.26 M(-8.3%) |
| Dec 2012 | -$19.90 M(-23.0%) | -$4.33 M(-8.8%) | -$19.90 M(-12.7%) |
| Sep 2012 | - | -$4.75 M(-10.7%) | -$22.80 M(-3.3%) |
| Jun 2012 | - | -$5.32 M(-3.1%) | -$23.57 M(-3.9%) |
| Mar 2012 | - | -$5.49 M(-24.0%) | -$24.52 M(-5.2%) |
| Dec 2011 | -$25.86 M(+43.8%) | -$7.23 M(+31.0%) | -$25.86 M(+5.0%) |
| Sep 2011 | - | -$5.52 M(-12.1%) | -$24.62 M(+2.6%) |
| Jun 2011 | - | -$6.28 M(-8.1%) | -$23.99 M(+4.0%) |
| Mar 2011 | - | -$6.83 M(+14.0%) | -$23.07 M(+28.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$17.98 M(-343.4%) | -$5.99 M(+22.6%) | -$17.98 M(+117.4%) |
| Sep 2010 | - | -$4.89 M(-8.8%) | -$8.27 M(+147.5%) |
| Jun 2010 | - | -$5.36 M(+207.8%) | -$3.34 M(-156.0%) |
| Mar 2010 | - | -$1.74 M(-146.8%) | $5.97 M(-19.2%) |
| Dec 2009 | $7.39 M(+1377.4%) | $3.72 M(+9195.0%) | $7.39 M(+91.8%) |
| Sep 2009 | - | $40.00 K(-99.0%) | $3.85 M(-29.0%) |
| Jun 2009 | - | $3.95 M(-1323.2%) | $5.42 M(+130.4%) |
| Mar 2009 | - | -$323.00 K(-276.5%) | $2.35 M(+371.0%) |
| Dec 2008 | $500.00 K(-103.4%) | $183.00 K(-88.7%) | $500.00 K(-111.1%) |
| Sep 2008 | - | $1.61 M(+83.2%) | -$4.50 M(-53.4%) |
| Jun 2008 | - | $881.00 K(-140.4%) | -$9.66 M(-30.8%) |
| Mar 2008 | - | -$2.18 M(-54.8%) | -$13.96 M(-5.2%) |
| Dec 2007 | -$14.73 M(-11.1%) | -$4.82 M(+36.0%) | -$14.73 M(+0.4%) |
| Sep 2007 | - | -$3.54 M(+3.4%) | -$14.66 M(-1.9%) |
| Jun 2007 | - | -$3.42 M(+16.3%) | -$14.95 M(-5.9%) |
| Mar 2007 | - | -$2.94 M(-38.1%) | -$15.89 M(-4.1%) |
| Dec 2006 | -$16.56 M(+19.8%) | -$4.76 M(+24.1%) | -$16.56 M(+5.5%) |
| Sep 2006 | - | -$3.83 M(-12.0%) | -$15.69 M(+6.0%) |
| Jun 2006 | - | -$4.36 M(+20.4%) | -$14.81 M(+4.6%) |
| Mar 2006 | - | -$3.62 M(-6.9%) | -$14.15 M(+2.4%) |
| Dec 2005 | -$13.82 M(+7.0%) | -$3.89 M(+31.8%) | -$13.82 M(+7.7%) |
| Sep 2005 | - | -$2.95 M(-20.3%) | -$12.83 M(-8.0%) |
| Jun 2005 | - | -$3.70 M(+12.4%) | -$13.95 M(+3.5%) |
| Mar 2005 | - | -$3.29 M(+13.5%) | -$13.47 M(+4.3%) |
| Dec 2004 | -$12.92 M(-25.7%) | -$2.90 M(-28.7%) | -$12.92 M(-11.1%) |
| Sep 2004 | - | -$4.06 M(+26.2%) | -$14.53 M(+2.9%) |
| Jun 2004 | - | -$3.22 M(+17.6%) | -$14.12 M(-6.2%) |
| Mar 2004 | - | -$2.74 M(-39.2%) | -$15.05 M(-14.5%) |
| Dec 2003 | -$17.39 M(-208.9%) | -$4.51 M(+23.3%) | -$17.61 M(+3.8%) |
| Sep 2003 | - | -$3.65 M(-11.9%) | -$16.97 M(-282.2%) |
| Jun 2003 | - | -$4.15 M(-21.7%) | $9.31 M(-21.8%) |
| Mar 2003 | - | -$5.30 M(+37.2%) | $11.91 M(-25.4%) |
| Dec 2002 | $15.97 M(+51.3%) | -$3.86 M(-117.1%) | $15.97 M(-58.3%) |
| Sep 2002 | - | $22.63 M(-1558.0%) | $38.30 M(+177.6%) |
| Jun 2002 | - | -$1.55 M(+25.4%) | $13.80 M(+15.9%) |
| Mar 2002 | - | -$1.24 M(-106.7%) | $11.90 M(+11.3%) |
| Dec 2001 | $10.56 M(-261.4%) | $18.47 M(-1082.5%) | $10.69 M(-216.4%) |
| Sep 2001 | - | -$1.88 M(-45.5%) | -$9.18 M(+6.5%) |
| Jun 2001 | - | -$3.45 M(+40.9%) | -$8.63 M(+25.5%) |
| Mar 2001 | - | -$2.45 M(+73.8%) | -$6.87 M(+5.7%) |
| Dec 2000 | -$6.54 M(-22.9%) | -$1.41 M(+6.5%) | -$6.50 M(+27.7%) |
| Sep 2000 | - | -$1.32 M(-21.9%) | -$5.09 M(+35.1%) |
| Jun 2000 | - | -$1.69 M(-18.4%) | -$3.77 M(+81.6%) |
| Mar 2000 | - | -$2.08 M | -$2.08 M |
| Dec 1999 | -$8.48 M(-63.2%) | - | - |
| Dec 1998 | -$23.05 M(-57.2%) | - | - |
| Dec 1997 | -$53.91 M(+15.4%) | - | - |
| Dec 1996 | -$46.73 M | - | - |
FAQ
- What is Idera Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals annual operating profit year-on-year change?
- What is Idera Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly operating profit year-on-year change?
- What is Idera Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals TTM operating profit year-on-year change?
What is Idera Pharmaceuticals annual operating income?
The current annual operating profit of IDRA is -$26.35 M
What is the all time high annual operating profit for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual operating income is $15.97 M
What is Idera Pharmaceuticals annual operating profit year-on-year change?
Over the past year, IDRA annual operating income has changed by +$10.34 M (+28.17%)
What is Idera Pharmaceuticals quarterly operating income?
The current quarterly operating profit of IDRA is -$3.69 M
What is the all time high quarterly operating profit for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly operating income is $22.63 M
What is Idera Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, IDRA quarterly operating income has changed by +$2.15 M (+36.81%)
What is Idera Pharmaceuticals TTM operating income?
The current TTM operating profit of IDRA is -$17.36 M
What is the all time high TTM operating profit for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high TTM operating income is $38.30 M
What is Idera Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, IDRA TTM operating income has changed by +$12.91 M (+42.66%)